A PILOT STUDY OF 566C80 FOR THE SALVAGE TREATMENT OF TOXOPLASMIC ENCEPHALITIS IN PATIENTS INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) WHO HAVE FAILED OR ARE INTOLERANT OF PYRIMETHAMINE-SULFADIAZINE: